Literature DB >> 12752485

How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures.

M Rahman1, S J Griffin, W Rathmann, N J Wareham.   

Abstract

AIMS: To test the accuracy of four measures of peripheral diabetic neuropathy in a primary care population.
METHODS: Type 2 diabetic (n = 544) and 544 non-diabetic participants aged 45-76 years were randomly selected from general practice registers. Neuropathy was assessed using vibration threshold (VT) and scores for light touch, thermal sense and modified Michigan Neuropathy Screening Instrument questionnaire. These measures were assessed for variation with diabetes status, age, diabetes duration, HbA1c, and presence of retinopathy and nephropathy. Light touch, thermal sense and questionnaire scores were assessed against VT using ROC curve analysis.
RESULTS: Only VT and light touch were different between diabetic and non-diabetic groups (P = 0.02 and < 0.0001, respectively). All measures were significantly associated with diabetes duration and retinopathy, and all except questionnaire score (P = 0.14) with age. None was associated with nephropathy and only questionnaire score was associated with HbA1c (P = 0.033). VT varied as expected across scores of light touch (chi2 = 41.65, P = 0.0001), thermal sense (chi2 = 15.86, P = 0.015) and questionnaire (chi2 = 21.22, P = 0.047). Area under the curve values for light touch, thermal and questionnaire scores were 0.72 (95% confidence interval (CI) 0.63, 0.82), 0.63 (95% CI 0.52, 0.73) and 0.64 (95% CI 0.53, 0.74), respectively.
CONCLUSIONS: All measures had associations with risk factors for neuropathy, but light touch score (monofilament) had the strongest association with vibration threshold (the chosen gold standard) and thus appeared the most appropriate tool for use in primary care, because of its validity and simplicity of use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752485     DOI: 10.1046/j.1464-5491.2003.00931.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  18 in total

Review 1.  Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review.

Authors:  Jacquelien Dros; Astrid Wewerinke; Patrick J Bindels; Henk C van Weert
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

Review 2.  [Diabetic neuropathy].

Authors:  Monika Lechleitner; Heidemarie Abrahamian; Claudia Francesconi; Markus Kofler
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

3.  How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort.

Authors:  M Rahman; R K Simmons; S H Hennings; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2012-01-12       Impact factor: 10.122

4.  In vivo confocal microscopy of corneal small fiber damage in diabetes mellitus.

Authors:  Elisabeth M Messmer; Christoph Schmid-Tannwald; Daniel Zapp; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-21       Impact factor: 3.117

5.  Clinical Response to Real-Time Patient-Reported Diabetic Peripheral Neuropathy Symptoms.

Authors:  Somalee Banerjee; Eileen Kim; Melissa M Parker; Lisa K Gilliam; Rick Dlott; Alyce Adams
Journal:  Perm J       Date:  2019

6.  [Diabetic neuropathy].

Authors:  Monika Lechleitner; Heidemarie Abrahamian; Mario Francesconi
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

7.  Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study.

Authors:  Bruce A Perkins; Andrej Orszag; Mylan Ngo; Eduardo Ng; Patti New; Vera Bril
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

8.  Overcoming barriers to diabetic polyneuropathy management in primary care.

Authors:  Alyce S Adams; Brian Callaghan; Richard W Grant
Journal:  Healthc (Amst)       Date:  2016-12-07

9.  Comparison of shoe-length fit between people with and without diabetic peripheral neuropathy: a case-control study.

Authors:  Alistair D McInnes; Farina Hashmi; Lisa J Farndon; Amanda Church; Maria Haley; Debora M Sanger; Wesley Vernon
Journal:  J Foot Ankle Res       Date:  2012-04-16       Impact factor: 2.303

10.  The prevalence of diabetic peripheral neuropathy and related factors.

Authors:  O Tabatabaei-Malazy; Mr Mohajeri-Tehrani; Sp Madani; R Heshmat; B Larijani
Journal:  Iran J Public Health       Date:  2011-09-30       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.